Which reflux treatment works best? major trial to find out
NCT ID NCT07611162
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will compare five treatments for laryngopharyngeal reflux disease (LPRD) in 800 adults. Participants will receive either alginate, magaldrate, sucralfate, a proton pump inhibitor, or a special diet for three months. Researchers will measure symptom improvement to see which approach is most effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
alginate, magaldrate, sucralfate, proton pump inhibitors, and diet
What this could lead to
If successful, this study could identify which treatment works best for laryngopharyngeal reflux, helping doctors choose the most effective and tolerable option.
What could go wrong
This is a single trial with 800 participants, and results may not apply to everyone. The study hasn't started yet, so outcomes are uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LARYNGOPHARYNGEAL REFLUX DISEASE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Mons
Mons, 7000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••